Cover Image
市場調查報告書

D. Western Therapeutics Institute, Inc.:產品平台分析

D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251660
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
D. Western Therapeutics Institute, Inc.:產品平台分析 D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 27 Pages
簡介

D. Western Therapeutics Institute, Inc.是致力於新藥開發的製藥公司,該公司的產品使用於閉塞性動脈硬化症、青光眼、高血壓等的治療藥,也製造抗癌藥。

這份報告提供D. Western Therapeutics Institute, Inc.的治療藥開發平台的現狀及各開發階段比較分析、藥物標的、作用機制、給藥途徑、各分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

D. Western Therapeutics Institute, Inc.的基本資料

D. Western Therapeutics Institute, Inc.概要

  • 主要資訊
  • 企業資料

D. Western Therapeutics Institute, Inc.:R&D概要

  • 主要的治療範圍

D. Western Therapeutics Institute, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

D. Western Therapeutics Institute, Inc.:開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

D. Western Therapeutics Institute, Inc.:藥物簡介

  • H-1129
  • H-1129 Backup
  • Small Molecule for Cardiovascular System
  • Small Molecule for Central Nervous System Disorders
  • Small Molecule for Ophthalmology
  • Small Molecule for Respiratory System

D. Western Therapeutics Institute, Inc.:開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

D. Western Therapeutics Institute, Inc.:暫停中的計劃

D. Western Therapeutics Institute, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07447CDB

Summary

Global Markets Direct's, 'D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2015', provides an overview of the D. Western Therapeutics Institute, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of D. Western Therapeutics Institute, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of D. Western Therapeutics Institute, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of D. Western Therapeutics Institute, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the D. Western Therapeutics Institute, Inc.'s pipeline products

Reasons to buy

  • Evaluate D. Western Therapeutics Institute, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of D. Western Therapeutics Institute, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the D. Western Therapeutics Institute, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of D. Western Therapeutics Institute, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of D. Western Therapeutics Institute, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of D. Western Therapeutics Institute, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • D. Western Therapeutics Institute, Inc. Snapshot
    • D. Western Therapeutics Institute, Inc. Overview
    • Key Information
    • Key Facts
  • D. Western Therapeutics Institute, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • D. Western Therapeutics Institute, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • D. Western Therapeutics Institute, Inc. - Pipeline Products Glance
    • D. Western Therapeutics Institute, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • D. Western Therapeutics Institute, Inc. - Drug Profiles
    • H-1129
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • H-1129 Backup
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Cardiovascular System
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Central Nervous System Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Ophthalmology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Respiratory System
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • D. Western Therapeutics Institute, Inc. - Pipeline Analysis
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Target
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Route of Administration
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Molecule Type
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Mechanism of Action
  • D. Western Therapeutics Institute, Inc. - Dormant Projects
  • D. Western Therapeutics Institute, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • D. Western Therapeutics Institute, Inc., Key Information
  • D. Western Therapeutics Institute, Inc., Key Facts
  • D. Western Therapeutics Institute, Inc. - Pipeline by Indication, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Stage of Development, 2015
  • D. Western Therapeutics Institute, Inc. - Monotherapy Products in Pipeline, 2015
  • D. Western Therapeutics Institute, Inc. - Out-Licensed Products in Pipeline, 2015
  • D. Western Therapeutics Institute, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • D. Western Therapeutics Institute, Inc. - Preclinical, 2015
  • D. Western Therapeutics Institute, Inc. - Discovery, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Target, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Route of Administration, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Molecule Type, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Mechanism of Action, 2015
  • D. Western Therapeutics Institute, Inc. - Dormant Developmental Projects,2015
  • D. Western Therapeutics Institute, Inc., Other Locations

List of Figures

  • D. Western Therapeutics Institute, Inc. - Pipeline by Top 10 Indication, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Stage of Development, 2015
  • D. Western Therapeutics Institute, Inc. - Monotherapy Products in Pipeline, 2015
  • D. Western Therapeutics Institute, Inc. - Out-Licensed Products in Pipeline, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Top 10 Target, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top